01—Abstract
Summary
Summary of the 8-K filed April 24, 2025. Cited figures are marked; the original filing is the authoritative source.
Dow Inc. reported first quarter 2025 results on April 24, 2025, with net sales of $10.4 billiona, down 3% year-over-year, and a GAAP net loss of $290 million (GAAP loss per share of $0.44).
Operating EBIT fell to $230 millionb from $674 million a year earlier, and operating EPS was $0.02 versus $0.56. Volume grew 2% year-over-year, a sixth consecutive quarter of volume gains, but local prices fell 3% and higher energy and feedstock costs compressed margins. Cash from continuing operations was $104 million, and free cash flow was negative $581 million after $685 million of capital expenditures.
Dividends of $494 millionc were paid in the quarter, which exceeded operating cash flow. Management announced an action plan to conserve cash, targeting roughly $6 billion in cash support. The plan includes up to $3 billion from a minority stake sale in U.S. Gulf Coast infrastructure assets to Macquarie Asset Management (first $2.4 billion tranche expected at closing on May 1), more than $1 billion in NOVA judgment proceeds in 2025, at least $1 billion in targeted cost savings by 2026 (about $300 million in 2025), and roughly $1 billion in 2025 capex reductions.
Dow is delaying construction of the Fort Saskatchewan Path2Zero project and cutting total 2025 enterprise capex to $2.5 billiond from $3.5 billion. The company is also expanding its European asset review, which now covers three additional upstream assets, including the Böhlen cracker, Schkopau chlor-alkali and vinyl assets, and the Barry siloxanes plant, with the full review to be completed by mid-2025. For investors, the key issues are the sharp earnings decline, negative free cash flow, and dividend coverage.
The asset sales and capex cuts are meaningful near-term support, but they depend on closing timelines and on the pace of the European restructuring. Restructuring and significant items totaled $416 million pretax in the quarter, and the outlook remains cautious given slow GDP growth and trade uncertainty.
02—Key points
Key Highlights
- Net sales of $10.4B (-3% YoY) with volume up 2% but local price down 3%; GAAP net loss of $290M, or -$0.44 per share
- Operating EBIT fell to $230M from $674M YoY; operating EPS was $0.02 versus $0.56 in 1Q24
- Cash from continuing operations was $104M, and free cash flow was -$581M; $494M in dividends paid exceeded operating cash flow
- Action plan targets ~$6B in cash support: up to $3B from Macquarie infrastructure stake sale ($2.4B first tranche at May 1 closing), >$1B NOVA judgment proceeds, ≥$1B cost savings by 2026, and ~$1B 2025 capex reduction
- Path2Zero Alberta project construction delayed; 2025 enterprise capex cut to $2.5B from $3.5B plan
- European asset review expanded to three more upstream assets (Böhlen ethylene cracker, Schkopau CAV assets, Barry siloxanes plant), with review completion targeted by mid-2025
- Significant items of $416M pretax in 1Q25, primarily restructuring and efficiency costs, plus a $60M loss on early debt extinguishment
03—Questions
Frequently Asked Questions
Why did Dow's earnings decline so sharply in the first quarter of 2025?
Operating EBIT fell $444 million year-over-year to $230 million, mainly due to lower prices and higher energy and feedstock costs. Volume gains partly offset these pressures, and the release cites soft global industry demand as the underlying driver.
Is Dow's dividend covered by cash flow?
Not in the first quarter. Dow paid $494 million in dividends, while cash from continuing operations was only $104 million and free cash flow was negative $581 million. The company is relying on asset sales and capex reductions to improve its cash position.
What is the Macquarie transaction and when will it close?
Dow plans to sell a minority stake in select U.S. Gulf Coast infrastructure assets to form Diamond Infrastructure Solutions with Macquarie Asset Management. Up to $3 billion in proceeds is expected in 2025, with the first $2.4 billion tranche anticipated at closing on May 1, 2025.
What are the main risks from the expanded European asset review?
Three upstream assets across all segments may be idled or shut down: the Böhlen ethylene cracker in Germany, the Schkopau chlor-alkali and vinyl assets in Germany, and the Barry siloxanes plant in the U.K. The review, which includes Polyurethanes options, is due to be completed by mid-2025. Outcomes could lead to further restructuring charges and reduced capacity.
Does the Path2Zero delay change Dow's long-term growth outlook?
Dow says it remains committed to Path2Zero, which it describes as a first-quartile asset with attractive returns. The company is delaying construction until market conditions improve, so the project's timing and contribution to growth are now deferred.
04—Continue